This fact sheet summarizes the work being done by PATH to develop two new tests to detect infection with cancer-causing human papillomavirus. Designed by the private sector—in partnership with PATH—for use in low-resource settings, these molecular and biochemical screening tools are an innovative answer to the challenge of preventing cervical cancer in the developing world.
Author(s): Lim J, Sellors J
Corporate author(s): PATH, QIAGEN, AVC
Publication date: December 2007
113 KB PDF
202 KB PDF
Also known as: ��?宫颈癌筛查的技术�?�新
109 KB PDF
Also known as: Innovadoras pruebas para la detección temprana del cáncer cervical
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA